These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4318814)

  • 1. The incidence of complement-fixing antibody to varicella-zoster virus in hospital patients and blood donors.
    Tomlinson AH; MacCallum FO
    J Hyg (Lond); 1970 Sep; 68(3):411-6. PubMed ID: 4318814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement fixing antibody to varicella-zoster virus in different age groups and after zoster.
    Moschen ME; Peserico A; Trivello R
    Boll Ist Sieroter Milan; 1977 Mar; 56(1):70-3. PubMed ID: 193530
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Specific immunoglobulin responses after varicella and herpes zoster.
    Cradock-Watson JE; Ridehalgh MK; Bourne MS
    J Hyg (Lond); 1979 Apr; 82(2):319-36. PubMed ID: 219110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunological relationship between herpes simplex and varicella-zoster viruses demonstrated by complement-fixation, neutralization and fluorescent antibody tests.
    Schmidt NJ; Lennette EH; Magoffin RL
    J Gen Virol; 1969 Apr; 4(3):321-8. PubMed ID: 4306713
    [No Abstract]   [Full Text] [Related]  

  • 5. Antigenic relationship between human cytomegalovirus, herpes simplex, and varicella-zoster virus studied by complement-fixation.
    Krech U; Jung M
    Arch Gesamte Virusforsch; 1971; 33(3):288-95. PubMed ID: 4329637
    [No Abstract]   [Full Text] [Related]  

  • 6. Antibody assays for varicella-zoster virus: comparison of enzyme immunoassay with neutralization, immune adherence hemagglutination, and complement fixation.
    Forghani B; Schmidt NJ; Dennis J
    J Clin Microbiol; 1978 Nov; 8(5):545-52. PubMed ID: 215602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening blood donors for high titre antibody to herpes varicella-zoster.
    Héjjas M; Salker R; Barbara JA
    Vox Sang; 1980 Dec; 39(6):335-8. PubMed ID: 6267817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complement fixing antibody to varicella-zoster virus in different age groups.
    Hata S
    J Dermatol; 1979 Jun; 6(3):197-200. PubMed ID: 231058
    [No Abstract]   [Full Text] [Related]  

  • 9. Age-specific prevalence of antibodies to pyrimidine kinase enzymes of herpes simplex virus types 1 and 2, and of varicella zoster virus.
    Bardy B; Seuna L; Hovi T
    J Med Virol; 1986 Jan; 18(1):61-7. PubMed ID: 3003247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of immune adherence hemagglutination test in the screening of blood donors carrying a high titer antibody to varicella-zoster virus.
    Kawai H; Sakuma T; Sasaki K; Sato M; Watanabe T; Honda M; Ozaki S; Azuma M
    Tohoku J Exp Med; 1986 Feb; 148(2):143-9. PubMed ID: 3008376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The etiologic agents of varicella and herpes zoster; serologic studies with the viruses as propagated in vitro.
    WELLER TH; WITTON HM
    J Exp Med; 1958 Dec; 108(6):869-90. PubMed ID: 13598817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between serum anti-varicella zoster virus antibody titer and time from onset of herpes zoster.
    Ihara H; Miyachi M; Imafuku S
    J Dermatol; 2018 Feb; 45(2):189-193. PubMed ID: 29239011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody to early antigens of varicella-zoster virus during varicella and zoster.
    Gerna G; Cereda PM; Cattaneo E; Achilli G; Gerna MT
    J Infect Dis; 1979 Jul; 140(1):33-41. PubMed ID: 88490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence of serum antibody titers against varicella zoster virus in Japanese patients with herpes zoster.
    Miyachi M; Ihara H; Imafuku S
    J Dermatol; 2017 Jun; 44(6):656-659. PubMed ID: 28012212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
    Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
    Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indirect haemagglutination reaction with varicella-zoster virus antigen.
    Trlifajová J; Pokorný J; Ryba M; Strízová V
    J Hyg Epidemiol Microbiol Immunol; 1973; 17(1):26-36. PubMed ID: 4350836
    [No Abstract]   [Full Text] [Related]  

  • 17. Serological studies on the antigenic relationship between herpes simplex virus and varicella-zoster virus.
    Wolff MH; Büchel F; Zoll A
    Immunobiology; 1979 Aug; 156(1-2):76-82. PubMed ID: 232073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous rise in complement-fixing antibodies against herpesvirus hominis and varicella-zostervirus in patients with chickenpox and shingles.
    Schaap GJ; Huisman J
    Arch Gesamte Virusforsch; 1968; 25(1):52-7. PubMed ID: 4306835
    [No Abstract]   [Full Text] [Related]  

  • 19. Complement fixing antibody to varicella-zoster virus in cancerous patients.
    Peserico A; Moschen ME; Romano M; Cartei G; Crivellari D; Trivello R
    Boll Ist Sieroter Milan; 1979 Sep; 58(4):335-8. PubMed ID: 233341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A practical method for preparation of varicella-zoster immune globulin.
    Zaia JA; Levin MJ; Wright GG; Grady GF
    J Infect Dis; 1978 May; 137(5):601-4. PubMed ID: 207788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.